Michael Hurwitz, MD, PhD < Yale School ...

Dr. Michael Hurwitz, MD, MPH, MsC

Claim this profile

Yale New Haven Hospital

Studies Non-Small Cell Lung Cancer
Studies Cancer
9 reported clinical trials
19 drugs studied

Area of expertise

1

Non-Small Cell Lung Cancer

Michael Hurwitz, MD, MPH, MsC has run 4 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
KRAS positive
2

Cancer

Michael Hurwitz, MD, MPH, MsC has run 4 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
HLA-A positive

Affiliated Hospitals

Image of trial facility.

Yale New Haven Hospital

Image of trial facility.

Yale Cancer Center

Clinical Trials Michael Hurwitz, MD, MPH, MsC is currently running

More about Michael Hurwitz, MD, MPH, MsC

Clinical Trial Related

3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Michael Hurwitz, MD, MPH, MsC has experience with

  • LYL797
  • ATL001
  • Pembrolizumab
  • Tumor Infiltrating Lymphocytes (TIL) LN-145
  • TSC-204-A0201
  • TSC-200-A0201

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Michael Hurwitz, MD, MPH, MsC specialize in?

Is Michael Hurwitz, MD, MPH, MsC currently recruiting for clinical trials?

Are there any treatments that Michael Hurwitz, MD, MPH, MsC has studied deeply?

What is the best way to schedule an appointment with Michael Hurwitz, MD, MPH, MsC?

What is the office address of Michael Hurwitz, MD, MPH, MsC?

Is there any support for travel costs?